IGFBP1 and colorectal carcinoma: Furthermore, Kaplan–Meier revealed that the 5-year OS of CRC patients with high serum IGFBP- level was shorter than those with low serum IGFBP-1 level (16% vs 32%), and the difference was statistically significant (P = 0.019) (Fig. 4A).